Wellwish Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.26 M
- Revenue Growth 4.40%
- Profit Growth -105.78%
- Ebitda -88.53%
- Net Worth -1.78%
- Total Assets -13.71%
About Wellwish Pharma
Wellwish Pharma Private Limited (WPPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 July 2013 and has a history of 11 years and six months. Its registered office is in Nagpur, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.26 M.
Ajay Satphale and Harish Khobragade serve as directors at the Company.
Company Details
-
Location
Nagpur, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U33111MH2013PTC245851
-
Company No.
245851
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
18 Jul 2013
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Wellwish Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajay Satphale
|
Director | 02-Apr-2018 | Current |
|
Harish Khobragade
|
Director | 04-Nov-2020 | Current |
Financial Performance of Wellwish Pharma.
Wellwish Pharma Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 4.4% increase. The company also saw a substantial fall in profitability, with a 105.78% decrease in profit. The company's net worth dipped by a decrease of 1.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Wellwish Pharma?
In 2023, Wellwish Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹1.26 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.13 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 May 2022 | Hdfc Bank Limited | ₹1.26 M | Open |
How Many Employees Work at Wellwish Pharma?
Unlock and access historical data on people associated with Wellwish Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Wellwish Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wellwish Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
